pioglitazone has been researched along with Irritable Bowel Syndrome in 2 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Irritable Bowel Syndrome: A disorder with chronic or recurrent colonic symptoms without a clearcut etiology. This condition is characterized by chronic or recurrent ABDOMINAL PAIN, bloating, MUCUS in FECES, and an erratic disturbance of DEFECATION.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pioglitazone is a peroxisome proliferator-activated receptor (PPAR) γ agonist and, although it is mostly used as an antidiabetic agent, it has been reported to have analgesic effects." | 5.40 | Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide. ( Azary, S; Dehpour, AR; Gharedaghi, MH; Javidan, AN; Kazemi, MH; Khalifeh-Soltani, A; Moradi, K; Paragomi, P; Rahimian, R; Sakuma, S, 2014) |
| "Pioglitazone is a peroxisome proliferator-activated receptor (PPAR) γ agonist and, although it is mostly used as an antidiabetic agent, it has been reported to have analgesic effects." | 1.40 | Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide. ( Azary, S; Dehpour, AR; Gharedaghi, MH; Javidan, AN; Kazemi, MH; Khalifeh-Soltani, A; Moradi, K; Paragomi, P; Rahimian, R; Sakuma, S, 2014) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Nozu, T | 1 |
| Miyagishi, S | 1 |
| Nozu, R | 1 |
| Takakusaki, K | 1 |
| Okumura, T | 1 |
| Paragomi, P | 1 |
| Rahimian, R | 1 |
| Kazemi, MH | 1 |
| Gharedaghi, MH | 1 |
| Khalifeh-Soltani, A | 1 |
| Azary, S | 1 |
| Javidan, AN | 1 |
| Moradi, K | 1 |
| Sakuma, S | 1 |
| Dehpour, AR | 1 |
2 other studies available for pioglitazone and Irritable Bowel Syndrome
| Article | Year |
|---|---|
Pioglitazone improves visceral sensation and colonic permeability in a rat model of irritable bowel syndrome.
Topics: Animals; Colon; Disease Models, Animal; Hyperalgesia; Hypoglycemic Agents; Irritable Bowel Syndrome; | 2019 |
Antinociceptive and antidiarrheal effects of pioglitazone in a rat model of diarrhoea-predominant irritable bowel syndrome: role of nitric oxide.
Topics: Analgesics; Animals; Antidiarrheals; Diarrhea; Disease Models, Animal; Irritable Bowel Syndrome; Mal | 2014 |